These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28713044)

  • 1. Reply letter to: Economic evaluations of clinician training - make your research meaningful to decision makers.
    Theilen U; Fraser L; Jones P; Leonard P; Simpson D
    Resuscitation; 2017 Oct; 119():e3-e4. PubMed ID: 28713044
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Theilen et al 2017: Economic evaluations of clinician training - Make your research meaningful to decision makers.
    Foo J; Maloney S
    Resuscitation; 2017 Oct; 119():e1. PubMed ID: 28625865
    [No Abstract]   [Full Text] [Related]  

  • 3. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
    Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
    Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluations of health technologies in Dutch healthcare decision-making: a qualitative study of the current and potential use, barriers, and facilitators.
    Roseboom KJ; van Dongen JM; Tompa E; van Tulder MW; Bosmans JE
    BMC Health Serv Res; 2017 Jan; 17(1):89. PubMed ID: 28126005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging the gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake.
    Merlo G; Page K; Ratcliffe J; Halton K; Graves N
    Appl Health Econ Health Policy; 2015 Jun; 13(3):303-9. PubMed ID: 25288052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines.
    Brinsmead R; Hill S; Walker D
    Pediatr Infect Dis J; 2004 Jan; 23(1):32-7. PubMed ID: 14743043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health economic decision-making: a comparison between UK and Spain.
    Corbacho B; Pinto-Prades JL
    Br Med Bull; 2012 Sep; 103(1):5-20. PubMed ID: 22833571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMET Project.
    Zwart-van Rijkom JE; Leufkens HG; Busschbach JJ; Broekmans AW; Rutten FF
    Pharmacoeconomics; 2000 Aug; 18(2):149-60. PubMed ID: 11067649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing decision-makers' access to economic evaluations: alternative methods of communicating the information.
    Thurston SJ; Craig D; Wilson P; Drummond MF
    Int J Technol Assess Health Care; 2008; 24(2):151-7. PubMed ID: 18400117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative study.
    Chen LC; Ashcroft DM; Elliott RA
    Pharm World Sci; 2007 Dec; 29(6):661-70. PubMed ID: 17566869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.
    Welte R; Trotter CL; Edmunds WJ; Postma MJ; Beutels P
    Pharmacoeconomics; 2005; 23(9):855-74. PubMed ID: 16153131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using economic evaluations to reduce the burden of asthma and chronic obstructive pulmonary disease.
    Sculpher M
    Pharmacoeconomics; 2001; 19 Suppl 2():21-5. PubMed ID: 11700785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluations of healthcare programmes and decision making: the influence of economic evaluations on different healthcare decision-making levels.
    van Velden ME; Severens JL; Novak A
    Pharmacoeconomics; 2005; 23(11):1075-82. PubMed ID: 16277545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting cost-effectiveness analysis for preventive interventions: a guide for decision makers.
    Teutsch SM; Murray JF
    Am J Manag Care; 1999 Mar; 5(3):301-5. PubMed ID: 10351026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluations of point of care testing strategies for active tuberculosis.
    Zwerling A; Dowdy D
    Expert Rev Pharmacoecon Outcomes Res; 2013 Jun; 13(3):313-25. PubMed ID: 23763529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? : a critical review of published Korean economic evaluations.
    Lee KS; Brouwer WB; Lee SI; Koo HW
    Pharmacoeconomics; 2005; 23(7):709-21. PubMed ID: 15987227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assessment of health economic evaluation.
    Chaikledkaew U; Kittrongsiri K
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S113-8. PubMed ID: 24964708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Economic evaluations more and more important in healthcare decision making. Costs must be balanced against benefits also in studies on health economics].
    Lundkvist J
    Lakartidningen; 2006 Nov 15-21; 103(46):3624-7. PubMed ID: 17153872
    [No Abstract]   [Full Text] [Related]  

  • 19. A census of economic evaluations in health promotion.
    Rush B; Shiell A; Hawe P
    Health Educ Res; 2004 Dec; 19(6):707-19. PubMed ID: 15199000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.